201 related articles for article (PubMed ID: 21042587)
1. Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.
Bouligand J; Delemer B; Hecart AC; Meduri G; Viengchareun S; Amazit L; Trabado S; Fève B; Guiochon-Mantel A; Young J; Lombès M
PLoS One; 2010 Oct; 5(10):e13563. PubMed ID: 21042587
[TBL] [Abstract][Full Text] [Related]
2. Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.
Vitellius G; Delemer B; Caron P; Chabre O; Bouligand J; Pussard E; Trabado S; Lombes M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5205-5216. PubMed ID: 31225872
[TBL] [Abstract][Full Text] [Related]
3. Significant prevalence of
Vitellius G; Trabado S; Hoeffel C; Bouligand J; Bennet A; Castinetti F; Decoudier B; Guiochon-Mantel A; Lombes M; Delemer B;
Eur J Endocrinol; 2018 Apr; 178(4):411-423. PubMed ID: 29444898
[TBL] [Abstract][Full Text] [Related]
4. Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation.
Trebble P; Matthews L; Blaikley J; Wayte AW; Black GC; Wilton A; Ray DW
J Clin Endocrinol Metab; 2010 Dec; 95(12):E490-9. PubMed ID: 20861124
[TBL] [Abstract][Full Text] [Related]
5. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene.
Mendonca BB; Leite MV; de Castro M; Kino T; Elias LL; Bachega TA; Arnhold IJ; Chrousos GP; Latronico AC
J Clin Endocrinol Metab; 2002 Apr; 87(4):1805-9. PubMed ID: 11932321
[TBL] [Abstract][Full Text] [Related]
6. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Glucocorticoid Signaling.
Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
[TBL] [Abstract][Full Text] [Related]
8. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene.
Karl M; Lamberts SW; Detera-Wadleigh SD; Encio IJ; Stratakis CA; Hurley DM; Accili D; Chrousos GP
J Clin Endocrinol Metab; 1993 Mar; 76(3):683-9. PubMed ID: 8445027
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas.
Maser-Gluth C; Reincke M; Allolio B; Schulze E
Eur J Clin Invest; 2000 Dec; 30 Suppl 3():83-6. PubMed ID: 11281375
[TBL] [Abstract][Full Text] [Related]
10. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
[TBL] [Abstract][Full Text] [Related]
11. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
[TBL] [Abstract][Full Text] [Related]
12. Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance.
Vitellius G; Fagart J; Delemer B; Amazit L; Ramos N; Bouligand J; Le Billan F; Castinetti F; Guiochon-Mantel A; Trabado S; Lombès M
Hum Mutat; 2016 Aug; 37(8):794-803. PubMed ID: 27120390
[TBL] [Abstract][Full Text] [Related]
13. Primary cortisol resistance: a familial syndrome and an animal model.
Chrousos GP; Loriaux DL; Brandon D; Tomita M; Vingerhoeds AC; Merriam GR; Johnson EO; Lipsett MB
J Steroid Biochem; 1983 Jul; 19(1B):567-75. PubMed ID: 6887885
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation in a family with primary cortisol resistance: possible modulating effect of the ER22/23EK polymorphism.
Raef H; Baitei EY; Zou M; Shi Y
Eur J Endocrinol; 2008 Apr; 158(4):577-82. PubMed ID: 18362306
[TBL] [Abstract][Full Text] [Related]
15. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
16. Salt-Sensitive Hypertension in GR
Vanderriele PE; Wang Q; Mérillat AM; Ino F; Aeschlimann G; Ehret X; Ancin Del Olmo D; Ponce de León V; Scholl UI; Winter DV; Odermatt A; Hummler E; Verouti SN
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948014
[TBL] [Abstract][Full Text] [Related]
17. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
Charmandari E; Kino T; Chrousos GP
Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
[TBL] [Abstract][Full Text] [Related]
18. Decreased hippocampal mineralocorticoid:glucocorticoid receptor ratio is associated with low birth weight in female cynomolgus macaque neonates.
Ong SX; Chng K; Meaney MJ; Buschdorf JP
J Mol Endocrinol; 2013; 51(1):59-67. PubMed ID: 23592886
[TBL] [Abstract][Full Text] [Related]
19. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid and mineralocorticoid receptors and associated diseases.
Kino T; Chrousos GP
Essays Biochem; 2004; 40():137-55. PubMed ID: 15242344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
